Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | JS009 |
| Trade Name | |
| Synonyms | JS-009|JS 009|TAB009|TAB-009|TAB 009 |
| Drug Descriptions |
JS009 is a monoclonal antibody that binds to PVRIG (CD112R) expressed on cytotoxic T-lymphocytes and NK cells and blocks its interaction with CD112, which potentially induces antitumor immune response and decreases tumor cell proliferation (NCI Drug Dictionary). |
| DrugClasses | PVRIG Antibody 5 |
| CAS Registry Number | NA |
| NCIT ID | C198987 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| JS006 + JS009 + Toripalimab-tpzi | JS006 JS009 Toripalimab-tpzi | 0 | 1 |
| JS009 | JS009 | 0 | 1 |